These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31009664)

  • 21. Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib.
    Lee JS; Huh CH; Kwon O; Yoon HS; Cho S; Park HS
    J Dermatolog Treat; 2018 Dec; 29(8):819-822. PubMed ID: 29658800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis.
    Valenzuela F; Papp KA; Pariser D; Tyring SK; Wolk R; Buonanno M; Wang J; Tan H; Valdez H
    BMC Dermatol; 2015 May; 15():8. PubMed ID: 25951857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative Treatment.
    Kurtzman DJ; Wright NA; Lin J; Femia AN; Merola JF; Patel M; Vleugels RA
    JAMA Dermatol; 2016 Aug; 152(8):944-5. PubMed ID: 27120749
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
    Cheng MW; Kehl A; Worswick S; Goh C
    J Drugs Dermatol; 2018 Jul; 17(7):800-803. PubMed ID: 30005104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repigmentation of acral vitiligo with tofacitinib combined with NB-UVB phototherapy: A case report.
    Sun XK; Xu AE
    Australas J Dermatol; 2023 Nov; 64(4):571-572. PubMed ID: 37635652
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation.
    Li Y; Huo J; Cao Y; Yu M; Zhang Y; Li Z; Li C; Zhang W
    Ann Rheum Dis; 2020 Sep; 79(9):1255-1257. PubMed ID: 32332076
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
    Charles-Schoeman C; van der Heijde D; Burmester GR; Nash P; Zerbini CAF; Connell CA; Fan H; Kwok K; Bananis E; Fleischmann R
    J Rheumatol; 2018 Feb; 45(2):177-187. PubMed ID: 29142036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next generation of small molecules in inflammatory bowel disease.
    Olivera P; Danese S; Peyrin-Biroulet L
    Gut; 2017 Feb; 66(2):199-209. PubMed ID: 27856614
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study.
    Syal G; Mishkin DS; Banty A; Lee S; Fontelera N; Hampton M; Ziring D; Fleshner PR; Melmed GY
    Inflamm Bowel Dis; 2024 Oct; 30(10):1907-1910. PubMed ID: 37898112
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of low-dose tofacitinib combining narrowband UVB therapy for treating vitiligo patients who had failed previous therapy: A pilot study.
    Fang WC; Chiu SH; Lin SY; Huang SM; Lan CE
    Photodermatol Photoimmunol Photomed; 2021 Jul; 37(4):345-347. PubMed ID: 33512041
    [No Abstract]   [Full Text] [Related]  

  • 31. [Systemic treatment of vitiligo : Balance and current developments].
    Meurer M; Ceric-Dehdari P
    Hautarzt; 2017 Nov; 68(11):876-884. PubMed ID: 29030646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tofacitinib: A Review in Psoriatic Arthritis.
    Paik J; Deeks ED
    Drugs; 2019 Apr; 79(6):655-663. PubMed ID: 30895473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study Design.
    Ports WC; Feldman SR; Gupta P; Tan H; Johnson TR; Bissonnette R
    J Drugs Dermatol; 2015 Aug; 14(8):777-84. PubMed ID: 26267721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Tofacitinib Treatment of Erosive Pustular Dermatosis of the Scalp.
    Leung N; Eldik H; Ramirez MR; Sodha P
    JAMA Dermatol; 2019 Jun; 155(6):752-754. PubMed ID: 30969310
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series.
    Park HS; Kim MW; Lee JS; Yoon HS; Huh CH; Kwon O; Cho S
    J Am Acad Dermatol; 2017 Nov; 77(5):978-980. PubMed ID: 29029911
    [No Abstract]   [Full Text] [Related]  

  • 36. Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment.
    Lam C; Ferguson ID; Mariano MC; Lin YT; Murnane M; Liu H; Smith GA; Wong SW; Taunton J; Liu JO; Mitsiades CS; Hann BC; Aftab BT; Wiita AP
    Haematologica; 2018 Jul; 103(7):1218-1228. PubMed ID: 29622655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib.
    Winthrop KL; Wouters A; Choy EH; Chen C; Biswas P; Wang L; Soma K; Needle E; Valdez H; Rigby WF
    Ann Rheum Dis; 2020 May; 79(5):669-671. PubMed ID: 32161057
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III.
    Cohen SB; Koenig A; Wang L; Kwok K; Mebus CA; Riese R; Fleischmann R
    Clin Exp Rheumatol; 2016; 34(1):32-6. PubMed ID: 26575982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.
    Tanaka Y; Yamaoka K
    Mod Rheumatol; 2013 May; 23(3):415-24. PubMed ID: 23212593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis.
    Castelo-Soccio L
    J Am Acad Dermatol; 2017 Apr; 76(4):754-755. PubMed ID: 28325392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.